Literature DB >> 22221575

Repeated pancreatectomy after pancreato-duodenectomy for a intraductal papillary mucinous tumour: advantage of pancreatico-gastrostomy with a gastric partition.

Laureano Fernández-Cruz1, Miguel-Angel López-Boado, Joana Ferrer.   

Abstract

BACKGROUND: Regular follow-up and monitoring of intraductal papillary mucinous neoplasms (IPMN) is important as there is a risk of recurrence in both the non-invasive and invasive IPMN.
METHODS: Three patients developed pancreatic remnant recurrence after a pancreatico-duodenectomy for IPMN. Pancreatico-gastrostomy anastomosis was performed in all patients. Long-term follow-up was performed with radiographical surveillance and by endoscopic gastroscopy.
RESULTS: Magnetic resonance imaging (MRI) and endoscopic ultrasonography (EUS) revealed in one patient, 2 years after surgery, a 3-cm mass at the site of the anastomosis and dilatation of the Wirsung duct >6 mm in two other patients (2 and 3 years after surgery, respectively). The diagnosis of recurrence was confirmed endoscopically by the presence of a large amount of mucin at the anastomotic site. Cytological examination revealed moderate dysplasia. Opacification of the Wirsung duct after endoscopic retrograde cholangiopancreatography (ERCP) was only possible in one patient in whom an irregular stenosis of the duct was observed.
CONCLUSIONS: Long-term follow-up of the pancreatic remnant after pancreato-duodenectomy for IPMN is better achieved with pancreatico-gastrostomy anastomosis.
© 2011 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Year:  2011        PMID: 22221575      PMCID: PMC3277056          DOI: 10.1111/j.1477-2574.2011.00415.x

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  16 in total

1.  Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Suresh T Chari; Dhiraj Yadav; Thomas C Smyrk; Eugene P DiMagno; Laurence J Miller; Massimo Raimondo; Jonathan E Clain; Ian A Norton; Randall K Pearson; Bret T Petersen; Maurits J Wiersema; Michael B Farnell; Michael G Sarr
Journal:  Gastroenterology       Date:  2002-11       Impact factor: 22.682

2.  Outcome after surgical resection of intraductal papillary and mucinous tumors of the pancreas.

Authors:  E Cuillerier; C Cellier; L Palazzo; J Devière; P Wind; F Rickaert; P H Cugnenc; M Cremer; J P Barbier
Journal:  Am J Gastroenterol       Date:  2000-02       Impact factor: 10.864

3.  Surgical management of intraductal papillary mucinous tumors of the pancreas: the role of routine frozen section of the surgical margin, intraoperative endoscopic staged biopsies of the Wirsung duct, and pancreaticogastric anastomosis.

Authors:  J F Gigot; P Deprez; C Sempoux; C Descamps; S Metairie; D Glineur; P Gianello
Journal:  Arch Surg       Date:  2001-11

4.  Intraductal papillary mucinous neoplasms of the pancreas: an increasingly recognized clinicopathologic entity.

Authors:  T A Sohn; C J Yeo; J L Cameron; C A Iacobuzio-Donahue; R H Hruban; K D Lillemoe
Journal:  Ann Surg       Date:  2001-09       Impact factor: 12.969

5.  Intraductal papillary mucinous neoplasms of the pancreas: CT patterns of recurrence and multiobserver performance in detecting recurrent neoplasm after surgical resection.

Authors:  Jared A Christensen; J G Fletcher; Jeff L Fidler; Peter B Wold; Aaron J Binstock; Thomas Smyrk; Scott W Harmsen; Brian S Crownhart; Suresh Chari
Journal:  AJR Am J Roentgenol       Date:  2004-11       Impact factor: 3.959

6.  Management of intraductal papillary mucinous tumours of the pancreas.

Authors:  F Navarro; J Michel; P Bauret; J Ramos; P Blanc; J M Fabre; B Millat; B Desrousseaux; J Domergue
Journal:  Eur J Surg       Date:  1999-01

7.  Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection.

Authors:  Roberto Salvia; Carlos Fernández-del Castillo; Claudio Bassi; Sarah P Thayer; Massimo Falconi; William Mantovani; Paolo Pederzoli; Andrew L Warshaw
Journal:  Ann Surg       Date:  2004-05       Impact factor: 12.969

8.  Intraductal papillary mucinous neoplasms of the pancreas: an analysis of clinicopathologic features and outcome.

Authors:  Michael D'Angelica; Murray F Brennan; Arief A Suriawinata; David Klimstra; Kevin C Conlon
Journal:  Ann Surg       Date:  2004-03       Impact factor: 12.969

9.  Pancreatogastrostomy with gastric partition after pylorus-preserving pancreatoduodenectomy versus conventional pancreatojejunostomy: a prospective randomized study.

Authors:  Laureano Fernández-Cruz; Rebeca Cosa; Laia Blanco; Miguel Angel López-Boado; Emiliano Astudillo
Journal:  Ann Surg       Date:  2008-12       Impact factor: 12.969

10.  Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.

Authors:  Taylor A Sohn; Charles J Yeo; John L Cameron; Ralph H Hruban; Noriyoshi Fukushima; Kurtis A Campbell; Keith D Lillemoe
Journal:  Ann Surg       Date:  2004-06       Impact factor: 12.969

View more
  2 in total

1.  Randomized controlled single-center trial comparing pancreatogastrostomy versus pancreaticojejunostomy after partial pancreatoduodenectomy.

Authors:  Ulrich F Wellner; Olivia Sick; Manfred Olschewski; Ulrich Adam; Ulrich T Hopt; Tobias Keck
Journal:  J Gastrointest Surg       Date:  2012-06-29       Impact factor: 3.452

Review 2.  [Pancreaticogastrostomy: when and how?]

Authors:  D Tittelbach-Helmrich; T Keck; U F Wellner
Journal:  Chirurg       Date:  2017-01       Impact factor: 0.955

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.